April 27, 2009Nutrition Reviews
New Recommendations for the Diagnosis and Treatment of Plasma Lipid Abnormalities
Population
Patients with plasma lipid abnormalities or at risk for coronary heart disease (CHD)
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
Updates lipid management protocols with risk stratification; extends prior guidelines for targeted CHD prevention.
Structured PICO
P
Population
Patients with plasma lipid abnormalities or at risk for coronary heart disease (CHD)
I
Intervention
Diet or diet and drug treatment for lowering LDL cholesterol
O
Outcome
Coronary heart disease morbidity and mortalityhard clinical
The ATP II guidelines provide updated, risk-stratified thresholds for initiating diet and pharmacological therapy to lower LDL cholesterol and reduce CHD risk.
Cite This Study
Ernst J. Schaefer (2009) studied this question.